# ClinicalTrials.gov record histories: tesamorelin

One section per trial; the section anchor is the lower-case NCT number. JSON twin: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json

- Trials: 10
- Manifest: https://peptidescanner.com/clinical-trials-history/v1/manifest.json

---

<a id="nct00608023"></a>

## ClinicalTrials.gov record history: NCT00608023

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct00608023-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct00608023
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `5a033963ca0bec7b12ff5bc9b5fa2680b87d4fa51c49a84483d517270d1115c5`

### Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

### Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2008-01-23 | 2008-01-23 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=1&tab=history) | `12e98db2ec3c733309e7a0ed1757dc6502526f82f1cc8af1a4f4281fdd01bbc0` |
| 2 | 2011-11-22 | 2011-11-22 | COMPLETED | INTERVENTIONAL | Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=2&tab=history) | `05edc770a8b22d48ba0cc0786d9113f1a43a75ac19333752e69a4f4e45cb4385` |
| 3 | 2013-11-25 | 2013-11-25 | COMPLETED | INTERVENTIONAL | Arms and Interventions, Outcome Measures, Sponsor/Collaborators, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=3&tab=history) | `b13b06f1ea0798629a4b43c7bd16fcdec4c9dc7dc93b3b7bf1af3f854f39643e` |
| 4 | 2013-11-27 | 2013-11-27 | COMPLETED | INTERVENTIONAL | Adverse Events, Baseline Characteristics, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=4&tab=history) | `bd416e533aab2bdc7ceb5cf757748cf2b7acbdf8498453ef37c05c0fce8e0d4a` |
| 5 | 2014-03-27 | 2014-03-27 | COMPLETED | INTERVENTIONAL | Adverse Events, Arms and Interventions, Baseline Characteristics, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=5&tab=history) | `f57cc52ec770a4eedbb4fe454c6b1ee3dc86dd6f2f6ec9823d62905e6ceb8628` |
| 6 | 2022-03-29 | 2022-03-29 | COMPLETED | INTERVENTIONAL | Outcome Measures (Results), Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=6&tab=history) | `0b35352604ec39a39acbd83e0cbbbb3ba73d04d766558cfc6aadb8cfe4ea6b3b` |
| 7 | 2022-03-30 | 2022-03-30 | COMPLETED | INTERVENTIONAL | Adverse Events, More Information, Study Description, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=7&tab=history) | `6b7efe6ea71363fd906bc70a8e03f917d36c7836df25d11c36243b3e08a33ce3` |
| 8 | 2022-09-16 | 2022-09-16 | COMPLETED | INTERVENTIONAL | Contacts/Locations, IPDSharing, Limitations and Caveats, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00608023?a=8&tab=history) | `12384bdc9ee3335b002f715019b68457abb1254d2fa8dde0e210961df86b1177` |

---

<a id="nct00850564"></a>

## ClinicalTrials.gov record history: NCT00850564

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct00850564-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct00850564
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `dba8e056f1257935ecaec16d5cc85739cfb245f88c302c7d36a779fad89db836`

### Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

### Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2009-02-23 | 2009-02-23 | RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00850564?a=1&tab=history) | `ff2fd4a0daec5c10c576b45e212ef52b652e545205d02e5aac5a5a4dc2e36e12` |
| 2 | 2009-08-06 | 2009-08-06 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00850564?a=2&tab=history) | `9b4152ec5c02ad2fe899695b034015c54659490a1253bafdeb35f1b89d52116b` |
| 3 | 2010-04-01 | 2010-04-01 | RECRUITING | INTERVENTIONAL | Sponsor/Collaborators, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00850564?a=3&tab=history) | `e4c8cdf6d2c03afda6e93748fba9e19be40e31c991fbf0bee22646c7b03f741d` |
| 4 | 2010-10-04 | 2010-10-04 | COMPLETED | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00850564?a=4&tab=history) | `3e693ede9402e834028091f08dad1ac4700dceba7bc46b1a94494e754620da3a` |
| 5 | 2011-03-03 | 2011-03-03 | COMPLETED | INTERVENTIONAL | Adverse Events, Baseline Characteristics, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, References, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00850564?a=5&tab=history) | `3f85d1698a905e338f070f9e3a3cb2f7c6e168b141eb8e12532a8d618d02b36a` |
| 6 | 2011-04-15 | 2011-04-15 | COMPLETED | INTERVENTIONAL | Adverse Events, Arms and Interventions, Baseline Characteristics, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00850564?a=6&tab=history) | `b4a2752190d036de168c9e73c9add2850436ae63165707484e994ebe8a742dbb` |

---

<a id="nct01263717"></a>

## ClinicalTrials.gov record history: NCT01263717

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct01263717-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct01263717
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `536bfc3f9f2f969383aee2b8ef5a32ca9b971f5fa7fe072509ccb1a9d3561f7c`

### Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

### Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2010-12-20 | 2010-12-20 | RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=1&tab=history) | `2b41403d6278e5a010b9a5b59b24b3e3b349fc37d31e10ea6380e011f6be074a` |
| 2 | 2011-04-15 | 2011-04-15 | RECRUITING | INTERVENTIONAL | Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=2&tab=history) | `a61a8728ceb4711d5a6f22b583b513fd4fa3a9003b0e79e0f7cad661f8e0aa43` |
| 3 | 2011-10-05 | 2011-10-05 | RECRUITING | INTERVENTIONAL | Sponsor/Collaborators, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=3&tab=history) | `12a4e4e036ace843520fe47cb7113476a4e9d7adf693ffdaa3b3340e1e3b55d9` |
| 4 | 2012-04-18 | 2012-04-18 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=4&tab=history) | `51580889575ff5893c6148419ce53dfa9338a929ce5048d5dc6521dd1190329a` |
| 5 | 2012-11-09 | 2012-11-09 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=5&tab=history) | `ef382093d098153dbee9344f8e49a4ec4b7db1501b66e2e82c8726d949336b75` |
| 6 | 2013-03-12 | 2013-03-12 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=6&tab=history) | `c6cb29561e47d1351e8be4a4a5e6ce7c2384fe71dd4dad5fc4ffbe9dae5f197e` |
| 7 | 2013-08-27 | 2013-08-27 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=7&tab=history) | `68f1fc3349bffb82fd0ad5d8031e4cb855283aa3b2f5bf6ff8e4072b25b14bbd` |
| 8 | 2014-05-02 | 2014-05-02 | COMPLETED | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=8&tab=history) | `68474d0ae059831658885b85e1daf3be404ed7991e247cdc2d65c2ba6cd0e639` |
| 9 | 2014-10-10 | 2014-10-10 | COMPLETED | INTERVENTIONAL | Adverse Events, Baseline Characteristics, Contacts/Locations, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, References, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=9&tab=history) | `91dda507d28b15877972684ae00a251797e09cd2bb8d0447661d69f592c3c7de` |
| 10 | 2017-09-28 | 2017-09-28 | COMPLETED | INTERVENTIONAL | Limitations and Caveats, Outcome Measures (Results), Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=10&tab=history) | `81f11902464f8176f00608d889b2378edbf3d351cc875f02532fea2df69c9e6e` |

---

<a id="nct02196831"></a>

## ClinicalTrials.gov record history: NCT02196831

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct02196831-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct02196831
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `7ed42b3d1bd8e46f2ed244fb816631235524d8503f8be577c90024b8c55ce008`

### Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

### Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2014-07-21 | 2014-07-21 | NOT_YET_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=1&tab=history) | `5299cdd2724b5604359d8a018327174b4b1c034ffa6839bf19f35005c7578a6a` |
| 2 | 2014-07-22 | 2014-07-22 | NOT_YET_RECRUITING | INTERVENTIONAL | Arms and Interventions, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=2&tab=history) | `e85bf6cfe45407434bd41789982f2b9448f7fdda9393bb7bbaa8614539018dc9` |
| 3 | 2014-10-14 | 2014-10-14 | NOT_YET_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=3&tab=history) | `3568932e42b915078affe8a488ee674cd8332357980425619431162c72f25eca` |
| 4 | 2015-02-18 | 2015-02-18 | NOT_YET_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=4&tab=history) | `95c06aa77b4751d92e57ac318d6f6c35caf38a06900c0654d4b25809bab42f61` |
| 5 | 2015-07-16 | 2015-07-16 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Eligibility, Oversight, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=5&tab=history) | `b56190243fdac7ec6a7c2846094f555d60b30fec4b286432e86a548280aa7c61` |
| 6 | 2015-10-28 | 2015-10-28 | RECRUITING | INTERVENTIONAL | Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=6&tab=history) | `55cc7a4380ef210c57c7c2941b161c97ac0dcca33cb5083f88bbfdae845cc893` |
| 7 | 2016-03-14 | 2016-03-14 | RECRUITING | INTERVENTIONAL | Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=7&tab=history) | `0952999c1188b9abffd1f2424c5b45b450e1fe2182b7312975e3afc121711b29` |
| 8 | 2016-08-19 | 2016-08-19 | RECRUITING | INTERVENTIONAL | Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=8&tab=history) | `1021acb14b218e9a75d8aa09359f7686b93e6b5b355ee42c3f77f45694365eda` |
| 9 | 2017-08-28 | 2017-08-28 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=9&tab=history) | `ea197453e41eae96ea4655088bd032d4dea31f570f03cc7e9e7a644a6a08dc5f` |
| 10 | 2018-02-03 | 2018-02-03 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=10&tab=history) | `a80087d13f24637633eff6a5b5456a572ccc284f5ca27a03219812cba6761f15` |
| 11 | 2018-10-19 | 2018-10-19 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=11&tab=history) | `5ca2ed070a4c79120b6ded802ab120226aa346d62016821938f40b94ab3f510f` |
| 13 | 2019-12-19 | 2019-12-19 | COMPLETED | INTERVENTIONAL | Adverse Events, Baseline Characteristics, Document Section, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=13&tab=history) | `02f4496c4b1afc021f348f0ebe1530845abd67853814d93caefce56f1380045c` |
| 14 | 2020-01-13 | 2020-01-13 | COMPLETED | INTERVENTIONAL | References, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02196831?a=14&tab=history) | `f2094e86e64d287b5ee185df577baf02a7383d61e3cf75e055e540727fae60b4` |

---

<a id="nct02553603"></a>

## ClinicalTrials.gov record history: NCT02553603

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct02553603-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct02553603
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `16f0be452236a49626f668b50450a012c4d9a21162ac8890ac72845bb6378642`

### Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

### Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2015-09-16 | 2015-09-16 | RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02553603?a=1&tab=history) | `da5b8baff648b7e7db741a9cc0113829f096399976b033ab74dd09eb7d18f537` |
| 2 | 2016-05-10 | 2016-05-10 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02553603?a=2&tab=history) | `4d3798e06c6d8ae75cfd1094d4d68b84c9b33178966b71e0367de99303b0049d` |
| 3 | 2017-08-15 | 2017-08-15 | RECRUITING | INTERVENTIONAL | Arms and Interventions, Contacts/Locations, Eligibility, Outcome Measures, Oversight, Sponsor/Collaborators, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02553603?a=3&tab=history) | `f1329b64f05bc074cc4ce63fd5fed2b32d4fc3adea517eacd469c54bba42e67a` |
| 4 | 2018-02-14 | 2018-02-14 | RECRUITING | INTERVENTIONAL | Arms and Interventions, Eligibility, Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02553603?a=4&tab=history) | `09debcfe7d47b3ecf9b0f84086a8df59b93d04fef6a9e76701ea3791134bd69e` |
| 5 | 2018-07-09 | 2018-07-09 | RECRUITING | INTERVENTIONAL | Sponsor/Collaborators, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02553603?a=5&tab=history) | `daa2f5785230ed956b31fdc3890de6ce71c1674364ed2c551d463ac299a05fef` |
| 6 | 2019-04-16 | 2019-04-16 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02553603?a=6&tab=history) | `37255e5525e0af29b785dbb8aab56c6769a09a9043897eddce346cd01c5dc431` |
| 7 | 2019-11-01 | 2019-11-01 | COMPLETED | INTERVENTIONAL | Contacts/Locations, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02553603?a=7&tab=history) | `c4053ffc6caad15f2a676dff3d199052cff489612a7cecca1dff586b1cacdc43` |

---

<a id="nct02572323"></a>

## ClinicalTrials.gov record history: NCT02572323

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct02572323-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct02572323
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `f413f47e99d96b0d9897c2f392a2cfaf933f4132290684711a729c18035dfcd7`

### Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

### Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2015-10-07 | 2015-10-07 | NOT_YET_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=1&tab=history) | `6bd60f5b566f040199bfeeaf06e358542d92944ba0c099d8e419e589447a5693` |
| 2 | 2015-10-21 | 2015-10-21 | NOT_YET_RECRUITING | INTERVENTIONAL | Contacts/Locations, Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=2&tab=history) | `ffa911dea2d4e6572bbba0349d36421ca67cc6863daa6180f54b9c43a14874c2` |
| 3 | 2016-02-04 | 2016-02-04 | NOT_YET_RECRUITING | INTERVENTIONAL | Eligibility, Study Description, Study Design, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=3&tab=history) | `29b5bc9d542adc0cc2bea293a36a6735ce69afbaa8079e303522ed63714e599b` |
| 4 | 2016-10-24 | 2016-10-24 | NOT_YET_RECRUITING | INTERVENTIONAL | Arms and Interventions, IPDSharing, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=4&tab=history) | `ca8913bdb74417659c11dd6d9341e59692f6f2a674ecdd81151575d350f14394` |
| 5 | 2017-02-16 | 2017-02-16 | RECRUITING | INTERVENTIONAL | Arms and Interventions, Contacts/Locations, Eligibility, Outcome Measures, Oversight, Study Description, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=5&tab=history) | `1cf1f9d3a43541a124d8a4ae2aabb5e1c9ab28fa24cc825e8fb4d9c4f908aef6` |
| 6 | 2017-10-24 | 2017-10-24 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Sponsor/Collaborators, Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=6&tab=history) | `340088aedcd318c2c05b0504ff75591bf9d8c4d68e281cd35740297dd3bde47a` |
| 7 | 2019-03-20 | 2019-03-20 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=7&tab=history) | `006d711c0b835e1d79d85f1846a980ceab4d82414b0fd313b3b01101cfb117da` |
| 8 | 2020-03-25 | 2020-03-25 | RECRUITING | INTERVENTIONAL | Arms and Interventions, Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=8&tab=history) | `577c9c404876ea63a8512ff7d7d6fa249a06ec2470eb340aa98638044080b99d` |
| 9 | 2021-04-30 | 2021-04-30 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Sponsor/Collaborators, Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=9&tab=history) | `54e97bd4b2e0e81b79ed3cfe6329135b6c4fcd0424c626d98f3b8eb451465847` |
| 10 | 2022-07-06 | 2022-07-06 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=10&tab=history) | `684674badf9c3aef1c0f508a6b6b7e72b8c711de227703c05dbf7d5a6972cc8e` |
| 11 | 2023-04-26 | 2023-04-26 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=11&tab=history) | `0af6d294ea6b92e9a46f30d148da1d5e9d33b3d3df0766a2ddff74a6659b9e11` |
| 12 | 2024-05-03 | 2024-05-03 | COMPLETED | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=12&tab=history) | `791d5de9875f5e1312124e28b875a9df95b92034d444da41fbd5d5baa79ab18f` |
| 16 | 2026-03-04 | 2026-03-04 | COMPLETED | INTERVENTIONAL | Outcome Measures, Outcome Measures (Results), Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02572323?a=16&tab=history) | `4a39e99be6d207917ddcd5d0d18e252f77ccd49071723dffc284594caefb96ff` |

---

<a id="nct03150511"></a>

## ClinicalTrials.gov record history: NCT03150511

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct03150511-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct03150511
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `72d25ea43fd00933a0d7827b638cd87396338005fcb55acc354da9c19f2ee678`

### Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

### Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2017-05-09 | 2017-05-09 | NOT_YET_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=1&tab=history) | `e2c332aaedfe89baf7539fe276e46ff8649357bad52b43cc85dd8a2f56fae09e` |
| 2 | 2018-02-13 | 2018-02-13 | NOT_YET_RECRUITING | INTERVENTIONAL | Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=2&tab=history) | `e84394272212165fc5ff66585a9f65d6b2c93d9ab1d536f1bf26532fa8609ac9` |
| 3 | 2018-05-22 | 2018-05-22 | NOT_YET_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=3&tab=history) | `de1d1a437c3686f30ea623cc34eb6fb0cc3ee9038c31e647d17bb49b5f5f5796` |
| 4 | 2018-07-12 | 2018-07-12 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=4&tab=history) | `d70db16e095712caa48c96b14ee8651c3c652781183c41549f5a46ef23f8b34c` |
| 5 | 2019-02-07 | 2019-02-07 | RECRUITING | INTERVENTIONAL | Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=5&tab=history) | `41e913a97f04e56e3dbb0b0abd31d19df38984155db9e147e03b67a51c64d27e` |
| 6 | 2019-05-09 | 2019-05-09 | RECRUITING | INTERVENTIONAL | Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=6&tab=history) | `e329745b8ade8021f1be7b02db3a895e430570e4df10c04ec2bf0ba87eebe005` |
| 7 | 2020-05-19 | 2020-05-19 | RECRUITING | INTERVENTIONAL | Sponsor/Collaborators, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=7&tab=history) | `db2fceb71ceb815e6aa023c8ab33fd209f8094847098b62064d3045ba7326ba1` |
| 8 | 2020-12-08 | 2020-12-08 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=8&tab=history) | `c0fff8afc9ef8f9862d661c79af5f00797aaa58a9aa55bbc850bacf3375458ff` |
| 9 | 2021-12-07 | 2021-12-07 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=9&tab=history) | `649c2ff774d1cbfde1c6f9aeb19c05ee9f9bea7d11061a38488b43343f2ff106` |
| 10 | 2022-12-06 | 2022-12-06 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Contacts/Locations, Eligibility, Outcome Measures, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=10&tab=history) | `40b81b0c89c379bf6a161ef8284b2b76bfad649dc43c3132e9ceac96a5b5aebb` |
| 11 | 2023-08-08 | 2023-08-08 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Outcome Measures, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=11&tab=history) | `d805c497d06796c67accf8fba4232da8a82f013f872d3fe02bc6a610b83e7d16` |
| 12 | 2024-09-04 | 2024-09-04 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=12&tab=history) | `38d314146b0ea3d320faba27626033778b6d402201c3ff9026ae64047a351ba4` |
| 13 | 2024-11-08 | 2024-11-08 | RECRUITING | INTERVENTIONAL | Arms and Interventions, Outcome Measures, Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=13&tab=history) | `607ea2a2a8db86d65dacc6768b4bb6a3752d76d5bf8f7612466c83333772dc00` |
| 14 | 2025-11-10 | 2025-11-10 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03150511?a=14&tab=history) | `1764ff87f83c14fe0e29b404cd422ea5e369a436969b17a6e80fcb25d676eb55` |

---

<a id="nct03375788"></a>

## ClinicalTrials.gov record history: NCT03375788

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct03375788-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct03375788
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `9d4b8b5d42abbf22db32d59f0931bf0bfd7d3905f2a6af2dbdfcebf215b1c23b`

### Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

### Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2017-12-13 | 2017-12-13 | NOT_YET_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=1&tab=history) | `f29ddafb86ac33f4f800e50592be16645a05af9fe21e4bb0c31e732c4d87e262` |
| 2 | 2017-12-15 | 2017-12-15 | NOT_YET_RECRUITING | INTERVENTIONAL | Arms and Interventions, Conditions, Outcome Measures, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=2&tab=history) | `9117437b792f307424d986653641ec22bd6dbd549eaa4b65e9ff5093d206eca6` |
| 3 | 2018-08-14 | 2018-08-14 | NOT_YET_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=3&tab=history) | `4f8a9d127855547d30fbda728f17cc25101035dc69f8acc1ee46c632bef7d731` |
| 4 | 2018-10-19 | 2018-10-19 | NOT_YET_RECRUITING | INTERVENTIONAL | Sponsor/Collaborators, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=4&tab=history) | `b7315ca1cefd241efc7d0949da64519ece42c7b51156a99e40ebed4b3c6cdf1f` |
| 5 | 2019-02-21 | 2019-02-21 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Outcome Measures, Sponsor/Collaborators, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=5&tab=history) | `5228676b5e5d0d95c5e9d1173d0731cf83c1f9907f17df52bafb851c9a9b1cec` |
| 6 | 2019-11-19 | 2019-11-19 | RECRUITING | INTERVENTIONAL | Arms and Interventions, Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=6&tab=history) | `431b08e31e2f8eb4ee344d1d1cd1f013bbe0bf53016e802b1e9787054b27a4f3` |
| 7 | 2021-03-29 | 2021-03-29 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=7&tab=history) | `6055a576b9bcce373580c16a15e1be38e2e119e8846d74ff28dbd7d6458d0c80` |
| 8 | 2022-08-11 | 2022-08-11 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=8&tab=history) | `500abdd7cad92b58eabac23d8084a163fb1402ede4c10e0feff6a68960fb3e6e` |
| 9 | 2023-05-29 | 2023-05-29 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=9&tab=history) | `5210e37bebab0d9673932c40b4902933a709f7f9d2aa06368974c7a37ad182c0` |
| 10 | 2024-09-11 | 2024-09-11 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Oversight, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=10&tab=history) | `7d6b65e6e69d2998a244a444c10068f395d048fdaee51e1555fe3b6b68670ac4` |
| 14 | 2025-11-06 | 2025-11-06 | COMPLETED | INTERVENTIONAL | Adverse Events, Outcome Measures, Outcome Measures (Results), Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03375788?a=14&tab=history) | `96f23bb33b391960f901b9ca8a45c8936b23118896ef6cd7f66df5a5e5d74c62` |

---

<a id="nct06554717"></a>

## ClinicalTrials.gov record history: NCT06554717

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct06554717-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct06554717
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `ee92be3befdcf2811a33bb204c26d1a6db98a95558e85ab68f6a5c7a275561ef`

### Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

### Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2024-08-12 | 2024-08-12 | NOT_YET_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06554717?a=1&tab=history) | `7f93b741341172798fc50195ef5e30cd1d74a92be4970c114483d91a80ce4f04` |
| 2 | 2024-08-15 | 2024-08-15 | NOT_YET_RECRUITING | INTERVENTIONAL | Outcome Measures, Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06554717?a=2&tab=history) | `87f32760202459f86c20309ac91c2942b1b7fd44fdb63a4e58856b240854d892` |
| 3 | 2025-04-25 | 2025-04-25 | NOT_YET_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06554717?a=3&tab=history) | `1e939aaa81b5e139fe2fb81b98f09dd0b3999597752665983d0312c08e349716` |
| 4 | 2025-05-23 | 2025-05-23 | NOT_YET_RECRUITING | INTERVENTIONAL | Arms and Interventions, Oversight, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06554717?a=4&tab=history) | `c7223ac8f46b7e2b1165555a08c69352b41ebca28d6169515e0a636a36b312bc` |
| 5 | 2025-07-28 | 2025-07-28 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06554717?a=5&tab=history) | `bec91eb5e6a368636be6da671e2b6979b66f7426005c6e4e85776d303a47328e` |
| 6 | 2026-05-13 | 2026-05-13 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06554717?a=6&tab=history) | `8b78805533f5ac233011f78fef2238be27fac2149c889d90cbf10c3158701ab7` |
| 7 | 2026-05-15 | 2026-05-15 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06554717?a=7&tab=history) | `32cb089f56934b121547fadc4eac8f12c646df6d3f5a11a39a6c225f515a42ed` |

---

<a id="nct07481734"></a>

## ClinicalTrials.gov record history: NCT07481734

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct07481734-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/peptides/tesamorelin.json#nct07481734
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `8edab4e114a94d34dd76930d4ca586449b115d37538b3be69f3c17d49d4d69ad`

### Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

### Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2026-03-14 | 2026-03-14 | RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07481734?a=1&tab=history) | `7f4f107e7b8f3dd9e0c3ca23e883ec1e67815093b9cab18e732947b85158c3f3` |

